Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer

Sonja Textor,Matthias Dürst,Lars Jansen,Rosita Accardi,Massimo Tommasino,Marcus J. Trunk,Angel Porgador,Carsten Watzl,Lutz Gissmann,Adelheid Cerwenka

DOI: https://doi.org/10.1002/ijc.23733

2008-11-15

International Journal of Cancer

Abstract:AbstractHuman papillomavirus‐induced cervical carcinomas often show impaired expression of MHC class I molecules resulting in the inability of tumor cells to directly present viral peptides to cytotoxic T lymphocytes. Loss of MHC class I expression combined with the expression of activating NK cell receptor ligands renders tumor cells potentially susceptible to NK cell attack. Thus, in this study, we analyzed the expression of activating NK cell receptor ligands, NK cell accumulation and activation status in situ in normal ectocervical tissue (NCT), cervical intraepithelial neoplasia (CIN) and squamous cervical carcinoma (CxCa). We observed that expression of the DNAM‐1 ligand CD155 was frequently upregulated in CxCa, but not in CIN. The NKG2D ligand MICA was upregulated in fewer CxCa biopsies. In contrast, another NKG2D ligand ULBP2 was preferentially expressed in differentiated epithelial cells of NCT. Increased numbers of NK cells were detected in CIN as compared to NCT and CxCa. Expression of activating NK cell receptor ligands combined with loss of MHC class I was not correlated with enhanced NK cell accumulation or activation status. Furthermore, we demonstrate that cervical cancer cell lines are killed by the NK cell line, NKL, in a NKG2D‐ and DNAM‐1‐dependent manner in vitro. Since a significant number of CxCa biopsies showed low MHC class I expression combined with high expression of one or more of the tested activating NK cell receptor ligands, we conclude that CxCa might be a promising target for NK cell‐based adoptive immunotherapy. © 2008 Wiley‐Liss, Inc.

oncology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the expression patterns of activating natural killer (NK) cell receptor ligands and their relationship with NK cell accumulation and activation status during the development of cervical cancer. Specifically, the study focused on the following points:

1. **Expression of activating NK cell receptor ligands**: The paper analyzed the expression of activating NK cell receptor ligands (such as CD155, MICA, and ULBP2) in normal vulvar tissue (NCT), cervical intraepithelial neoplasia (CIN), and squamous cervical cancer (CxCa). The differences in the expression of these ligands at different stages may reveal the immune escape mechanisms in the progression of cervical cancer.

2. **Expression of MHC class I molecules**: Since the absence or low expression of MHC class I molecules can increase the sensitivity of tumor cells to NK cell attacks, the study also explored the expression of MHC class I molecules in these tissues and evaluated their relationship with the expression of activating NK cell receptor ligands.

3. **Accumulation and activation status of NK cells**: The researchers detected the density of NK cells and their activation status (such as CD56+CD16 - phenotype and IFN - γ production) in NCT, CIN, and CxCa by immunohistochemistry and immunofluorescence techniques to understand the distribution and functional changes of these cells at different lesion stages.

4. **In vitro experimental verification**: To further verify the above findings, the researchers used two HPV16 - positive cervical cancer cell lines (CaSki and SiHa) for in vitro experiments, tested the sensitivity of these cell lines to NK cell - mediated killing, and explored the roles of NKG2D and DNAM - 1 in this process.

In summary, the main purpose of this paper is to explore the immune escape mechanisms in the progression of cervical cancer and evaluate the potential application value of NK cells in the treatment of cervical cancer by analyzing the expression patterns of activating NK cell receptor ligands and MHC class I molecules, as well as the accumulation and activation status of NK cells.